CN
Company Introduction

HKND focuses on the global cutting-edge biotechnology field, through multi-level methods such as strategic investment, participation in operations, holding and steering, professional mergers and in-depth integration of high-quality assets in the global high-tech biological field.


By linking, aggregating and attracting global core technology industry projects in the field of life sciences, HKND aims to build a global cutting-edge biotechnology industry ecological development platform with cutting-edge research and development capabilities, top innovation and creation capabilities, and broad market development potential.


HKND uses the innovation management system to provide all-round empowerment for ecological enterprises, help and lead the efficient growth of ecological enterprises, move towards a more accessible capitalization path, and ultimately maximize the ecological value of the whole industrial chain.

  • Globalization
    headquartered in Singapore and Hong Kong, HKND is thinking globally and explores the most cutting-edge and valuable potential biotechnology M&A investment opportunities in the world.
  • High-tech
    HKND masters the cutting-edge core technology in the field of global life sciences, recruits the world's top scientific and technological talents, and creates high-tech innovation professional technical barriers with top R&D strength.
  • Big capital
    HKND gives full play to its strong capital energy and endowment core, provides strong financial support for its multiple ecological enterprises with an output value of over ten billion, and uses big capital to escort the development of ecological industry.
Core Values
Focus- Focusing on the Global Cutting-edge Biotechnology Field
HKND is an integrated M&A holding platform company focused on the global cutting-edge biotechnology industry, based on the research and development of life science technology, with the goal of cutting-edge innovative drug research and development, driven by AI and advanced data science, and focusing on the global cutting-edge biotechnology industry, committed to building a global leading biotechnology industry ecological development platform, headquartered in Singapore and Hong Kong, and explores the most cutting-edge, most valuable and potential biotech M&A opportunities on a global scale.
Persistence - Providing Core Power for High-quality Development with Science and Technology
We insist on leading innovation with science and technology, pursue, explore and develop core science and technology in the field of biomedicine, and aim to solve the most challenging health problems through the world's top technologies. Science and technology is the core driving force for the high-quality development of HKND. We have invested a lot of funds in the field of science and technology research and development to support the enterprise's high-tech research and development; We have recruited the world's top scientific and technological talents, and 80% of our core team members devote themselves to scientific research, creating the company's top scientific research strength and innovative professional technical barriers.
Excellence - Mastering the Core Technology in the Global Biomedical Field
The subdivisions we focus on cover cutting-edge new drug creation and development, digital life, innovative precision medical devices, IVD and precision medicine and other new medical technologies. At present, our ecological enterprises master the global multi-omics digital life ecosystem, the cutting-edge technology in the field of infection medicine and precision medicine, the most cutting-edge oncolytic bacterial immunotherapy technology in the field of tumor immunotherapy, as well as the important core technologies in the global biomedical field such as AI + new drug research and development, so as to temper excellent quality in the field of high-tech innovation and R&D.
Co-progress - Comprehensive Empowerment to help Ecological Enterprises Develop
Relying on the profound scientific and technological precipitation and connotation and relying on the scientific research expert team from many fields such as computing science, synthetic biology and drug discovery, HKND is committed to building a holding investment and development platform with multi-dimensional endowment energy through all-round empowerment of capital, resources and talents, and deeply participating in the whole life cycle of the development of biotechnology enterprises, lay a professional and efficient capitalization path for ecological enterprises, operate and grow together with ecological enterprises, achieve win-win progress, and achieve long-term sustainable and high-quality growth.
Mission & Vision
Relying on its global leading cutting-edge biotechnology ecological industry development platform, HKND is committed to comprehensively and systematically solving the most challenging human health problems, taking this opportunity to deeply explore the nature of life activities and the law of development, relying on the power of science and technology to realize the three-dimensional perception, effective control, and even active transformation and management of life activities, making positive contributions to improving global health and benefiting human society.